Hyperfine, Inc. HYPR

Company Overview

Hyperfine, Inc. (NASDAQ: HYPR) is a U.S.-based medical technology company focused on portable magnetic resonance imaging (MRI) systems and AI-enabled neuroimaging solutions. The company operates in the healthcare technology and medical imaging industries, with a primary emphasis on expanding access to diagnostic imaging in settings where conventional MRI systems are impractical due to cost, infrastructure, or mobility constraints. Hyperfine’s flagship product is the FDA-cleared Swoop Portable MR Imaging System, a low-field portable MRI device designed for bedside neuroimaging in hospitals, intensive care units, emergency departments, and other point-of-care environments.

The company generates revenue primarily through sales and leasing of MRI systems, recurring software and service agreements, and related consumables and support services. Hyperfine’s customer base includes hospitals, academic medical centers, healthcare systems, and research institutions. The company positions itself as a differentiated imaging provider through portability, lower installation requirements, reduced shielding and power demands compared with traditional MRI systems, and integration of artificial intelligence tools intended to improve workflow and image acquisition. Hyperfine was founded in 2014 by Jonathan Rothberg and evolved from a research-driven imaging startup into a publicly traded company following a business combination with a special purpose acquisition company in 2021.